nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO3A1—Methotrexate—ankylosing spondylitis	0.481	0.765	CbGbCtD
Alprostadil—ABCC4—Methotrexate—ankylosing spondylitis	0.148	0.235	CbGbCtD
Alprostadil—PTGER2—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.0222	0.131	CbGpPWpGaD
Alprostadil—Misoprostol—PTGER4—ankylosing spondylitis	0.0167	0.781	CrCbGaD
Alprostadil—PTGIR—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.015	0.0888	CbGpPWpGaD
Alprostadil—PTGER1—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.015	0.0888	CbGpPWpGaD
Alprostadil—PTGER2—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.0148	0.0874	CbGpPWpGaD
Alprostadil—PTGER2—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0122	0.0723	CbGpPWpGaD
Alprostadil—PTGIR—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.00998	0.059	CbGpPWpGaD
Alprostadil—PTGER1—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.00998	0.059	CbGpPWpGaD
Alprostadil—PTGER2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00849	0.0502	CbGpPWpGaD
Alprostadil—PTGIR—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00826	0.0488	CbGpPWpGaD
Alprostadil—PTGER1—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00826	0.0488	CbGpPWpGaD
Alprostadil—PTGER1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00573	0.0339	CbGpPWpGaD
Alprostadil—PTGIR—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00573	0.0339	CbGpPWpGaD
Alprostadil—Dinoprostone—PTGER4—ankylosing spondylitis	0.00467	0.219	CrCbGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00277	0.0164	CbGpPWpGaD
Alprostadil—PTGER2—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00273	0.0161	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00262	0.0155	CbGpPWpGaD
Alprostadil—ABCC5—Defective B3GAT3 causes JDSSDHD—B3GNT2—ankylosing spondylitis	0.00239	0.0141	CbGpPWpGaD
Alprostadil—PTGIR—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00184	0.0109	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00152	0.00899	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00152	0.00897	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00145	0.00859	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.0013	0.00769	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00128	0.00758	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00103	0.00606	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00103	0.00606	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00101	0.00596	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00099	0.00585	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000878	0.00519	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000878	0.00519	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000845	0.00499	CbGpPWpGaD
Alprostadil—Musculoskeletal stiffness—Methotrexate—ankylosing spondylitis	0.000788	0.00437	CcSEcCtD
Alprostadil—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000778	0.00431	CcSEcCtD
Alprostadil—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000778	0.00431	CcSEcCtD
Alprostadil—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.000777	0.00431	CcSEcCtD
Alprostadil—Injury—Dexamethasone—ankylosing spondylitis	0.000767	0.00425	CcSEcCtD
Alprostadil—Injury—Betamethasone—ankylosing spondylitis	0.000767	0.00425	CcSEcCtD
Alprostadil—Ecchymosis—Prednisone—ankylosing spondylitis	0.000765	0.00424	CcSEcCtD
Alprostadil—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000739	0.00409	CcSEcCtD
Alprostadil—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000737	0.00408	CcSEcCtD
Alprostadil—Sepsis—Prednisone—ankylosing spondylitis	0.000734	0.00407	CcSEcCtD
Alprostadil—Lethargy—Betamethasone—ankylosing spondylitis	0.00072	0.00399	CcSEcCtD
Alprostadil—Lethargy—Dexamethasone—ankylosing spondylitis	0.00072	0.00399	CcSEcCtD
Alprostadil—Sweating increased—Prednisolone—ankylosing spondylitis	0.000711	0.00394	CcSEcCtD
Alprostadil—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000706	0.00391	CcSEcCtD
Alprostadil—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.000677	0.00375	CcSEcCtD
Alprostadil—Influenza—Triamcinolone—ankylosing spondylitis	0.000672	0.00372	CcSEcCtD
Alprostadil—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000671	0.00371	CcSEcCtD
Alprostadil—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000671	0.00371	CcSEcCtD
Alprostadil—PTGIR—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000669	0.00395	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000669	0.00395	CbGpPWpGaD
Alprostadil—Injury—Prednisone—ankylosing spondylitis	0.000668	0.0037	CcSEcCtD
Alprostadil—Sweating increased—Triamcinolone—ankylosing spondylitis	0.000654	0.00362	CcSEcCtD
Alprostadil—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.000653	0.00362	CcSEcCtD
Alprostadil—Bronchitis—Triamcinolone—ankylosing spondylitis	0.000646	0.00358	CcSEcCtD
Alprostadil—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000642	0.00356	CcSEcCtD
Alprostadil—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000642	0.00356	CcSEcCtD
Alprostadil—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000642	0.00356	CcSEcCtD
Alprostadil—Ecchymosis—Methotrexate—ankylosing spondylitis	0.000639	0.00354	CcSEcCtD
Alprostadil—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000638	0.00354	CcSEcCtD
Alprostadil—Lethargy—Prednisone—ankylosing spondylitis	0.000627	0.00347	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000624	0.00346	CcSEcCtD
Alprostadil—ABCC5—Disease—ANTXR2—ankylosing spondylitis	0.000616	0.00364	CbGpPWpGaD
Alprostadil—Sepsis—Methotrexate—ankylosing spondylitis	0.000614	0.0034	CcSEcCtD
Alprostadil—Bradycardia—Prednisolone—ankylosing spondylitis	0.000595	0.0033	CcSEcCtD
Alprostadil—Sweating increased—Betamethasone—ankylosing spondylitis	0.000594	0.00329	CcSEcCtD
Alprostadil—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000594	0.00329	CcSEcCtD
Alprostadil—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00059	0.00327	CcSEcCtD
Alprostadil—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.00059	0.00327	CcSEcCtD
Alprostadil—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000589	0.00326	CcSEcCtD
Alprostadil—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000588	0.00326	CcSEcCtD
Alprostadil—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000587	0.00325	CcSEcCtD
Alprostadil—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000586	0.00324	CcSEcCtD
Alprostadil—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000585	0.00324	CcSEcCtD
Alprostadil—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000584	0.00323	CcSEcCtD
Alprostadil—Visual impairment—Prednisolone—ankylosing spondylitis	0.000563	0.00312	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00056	0.00331	CbGpPWpGaD
Alprostadil—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000559	0.0031	CcSEcCtD
Alprostadil—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00055	0.00305	CcSEcCtD
Alprostadil—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00055	0.00305	CcSEcCtD
Alprostadil—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000547	0.00303	CcSEcCtD
Alprostadil—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000546	0.00303	CcSEcCtD
Alprostadil—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00054	0.00299	CcSEcCtD
Alprostadil—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000539	0.00299	CcSEcCtD
Alprostadil—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000539	0.00299	CcSEcCtD
Alprostadil—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000538	0.00298	CcSEcCtD
Alprostadil—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000538	0.00298	CcSEcCtD
Alprostadil—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000536	0.00297	CcSEcCtD
Alprostadil—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000536	0.00297	CcSEcCtD
Alprostadil—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000536	0.00297	CcSEcCtD
Alprostadil—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000534	0.00296	CcSEcCtD
Alprostadil—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000533	0.00295	CcSEcCtD
Alprostadil—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000533	0.00295	CcSEcCtD
Alprostadil—Lethargy—Methotrexate—ankylosing spondylitis	0.000524	0.0029	CcSEcCtD
Alprostadil—Sweating increased—Prednisone—ankylosing spondylitis	0.000517	0.00286	CcSEcCtD
Alprostadil—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000517	0.00286	CcSEcCtD
Alprostadil—Erythema—Prednisolone—ankylosing spondylitis	0.000509	0.00282	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000508	0.003	CbGpPWpGaD
Alprostadil—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000497	0.00275	CcSEcCtD
Alprostadil—Bradycardia—Betamethasone—ankylosing spondylitis	0.000497	0.00275	CcSEcCtD
Alprostadil—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00049	0.00272	CcSEcCtD
Alprostadil—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00049	0.00272	CcSEcCtD
Alprostadil—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000488	0.0027	CcSEcCtD
Alprostadil—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000488	0.0027	CcSEcCtD
Alprostadil—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000479	0.00265	CcSEcCtD
Alprostadil—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00047	0.0026	CcSEcCtD
Alprostadil—Visual impairment—Betamethasone—ankylosing spondylitis	0.00047	0.0026	CcSEcCtD
Alprostadil—Erythema—Triamcinolone—ankylosing spondylitis	0.000468	0.00259	CcSEcCtD
Alprostadil—Erythema—Methylprednisolone—ankylosing spondylitis	0.000467	0.00259	CcSEcCtD
Alprostadil—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000467	0.00258	CcSEcCtD
Alprostadil—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000464	0.00257	CcSEcCtD
Alprostadil—Syncope—Prednisolone—ankylosing spondylitis	0.000456	0.00253	CcSEcCtD
Alprostadil—Back pain—Triamcinolone—ankylosing spondylitis	0.000453	0.00251	CcSEcCtD
Alprostadil—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000447	0.00248	CcSEcCtD
Alprostadil—Convulsion—Prednisolone—ankylosing spondylitis	0.000441	0.00244	CcSEcCtD
Alprostadil—Hypertension—Prednisolone—ankylosing spondylitis	0.000439	0.00243	CcSEcCtD
Alprostadil—Bradycardia—Prednisone—ankylosing spondylitis	0.000432	0.0024	CcSEcCtD
Alprostadil—Discomfort—Prednisolone—ankylosing spondylitis	0.000428	0.00237	CcSEcCtD
Alprostadil—Haemoglobin—Prednisone—ankylosing spondylitis	0.000427	0.00237	CcSEcCtD
Alprostadil—Haemorrhage—Prednisone—ankylosing spondylitis	0.000425	0.00235	CcSEcCtD
Alprostadil—Erythema—Dexamethasone—ankylosing spondylitis	0.000425	0.00235	CcSEcCtD
Alprostadil—Erythema—Betamethasone—ankylosing spondylitis	0.000425	0.00235	CcSEcCtD
Alprostadil—Syncope—Triamcinolone—ankylosing spondylitis	0.00042	0.00232	CcSEcCtD
Alprostadil—Syncope—Methylprednisolone—ankylosing spondylitis	0.000419	0.00232	CcSEcCtD
Alprostadil—Oedema—Prednisolone—ankylosing spondylitis	0.000415	0.0023	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000412	0.00228	CcSEcCtD
Alprostadil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000411	0.00228	CcSEcCtD
Alprostadil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00041	0.00227	CcSEcCtD
Alprostadil—Shock—Prednisolone—ankylosing spondylitis	0.000409	0.00226	CcSEcCtD
Alprostadil—Cough—Triamcinolone—ankylosing spondylitis	0.000408	0.00226	CcSEcCtD
Alprostadil—Convulsion—Triamcinolone—ankylosing spondylitis	0.000406	0.00225	CcSEcCtD
Alprostadil—Tachycardia—Prednisolone—ankylosing spondylitis	0.000405	0.00225	CcSEcCtD
Alprostadil—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000405	0.00224	CcSEcCtD
Alprostadil—Hypertension—Triamcinolone—ankylosing spondylitis	0.000404	0.00224	CcSEcCtD
Alprostadil—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000403	0.00223	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000402	0.00222	CcSEcCtD
Alprostadil—Flushing—Prednisone—ankylosing spondylitis	0.000394	0.00218	CcSEcCtD
Alprostadil—Discomfort—Triamcinolone—ankylosing spondylitis	0.000394	0.00218	CcSEcCtD
Alprostadil—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000393	0.00218	CcSEcCtD
Alprostadil—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00039	0.00216	CcSEcCtD
Alprostadil—Renal failure—Methotrexate—ankylosing spondylitis	0.000389	0.00215	CcSEcCtD
Alprostadil—Oedema—Triamcinolone—ankylosing spondylitis	0.000382	0.00212	CcSEcCtD
Alprostadil—Syncope—Dexamethasone—ankylosing spondylitis	0.000381	0.00211	CcSEcCtD
Alprostadil—Syncope—Betamethasone—ankylosing spondylitis	0.000381	0.00211	CcSEcCtD
Alprostadil—Infection—Triamcinolone—ankylosing spondylitis	0.000379	0.0021	CcSEcCtD
Alprostadil—Infection—Methylprednisolone—ankylosing spondylitis	0.000379	0.0021	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000378	0.00223	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000378	0.00223	CbGpPWpGaD
Alprostadil—Haematuria—Methotrexate—ankylosing spondylitis	0.000377	0.00209	CcSEcCtD
Alprostadil—Shock—Triamcinolone—ankylosing spondylitis	0.000376	0.00208	CcSEcCtD
Alprostadil—Shock—Methylprednisolone—ankylosing spondylitis	0.000375	0.00208	CcSEcCtD
Alprostadil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000373	0.00207	CcSEcCtD
Alprostadil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000373	0.00207	CcSEcCtD
Alprostadil—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000373	0.00207	CcSEcCtD
Alprostadil—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000372	0.00206	CcSEcCtD
Alprostadil—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00037	0.00205	CcSEcCtD
Alprostadil—Erythema—Prednisone—ankylosing spondylitis	0.00037	0.00205	CcSEcCtD
Alprostadil—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000369	0.00205	CcSEcCtD
Alprostadil—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000368	0.00204	CcSEcCtD
Alprostadil—Convulsion—Dexamethasone—ankylosing spondylitis	0.000368	0.00204	CcSEcCtD
Alprostadil—Convulsion—Betamethasone—ankylosing spondylitis	0.000368	0.00204	CcSEcCtD
Alprostadil—Hypertension—Dexamethasone—ankylosing spondylitis	0.000367	0.00203	CcSEcCtD
Alprostadil—Hypertension—Betamethasone—ankylosing spondylitis	0.000367	0.00203	CcSEcCtD
Alprostadil—ABCC5—Disease—B3GNT2—ankylosing spondylitis	0.000363	0.00215	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000362	0.00214	CbGpPWpGaD
Alprostadil—Discomfort—Dexamethasone—ankylosing spondylitis	0.000357	0.00198	CcSEcCtD
Alprostadil—Discomfort—Betamethasone—ankylosing spondylitis	0.000357	0.00198	CcSEcCtD
Alprostadil—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000357	0.00198	CcSEcCtD
Alprostadil—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000356	0.00197	CcSEcCtD
Alprostadil—Pain—Prednisolone—ankylosing spondylitis	0.000355	0.00197	CcSEcCtD
Alprostadil—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000355	0.00197	CcSEcCtD
Alprostadil—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000352	0.00195	CcSEcCtD
Alprostadil—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000348	0.00193	CcSEcCtD
Alprostadil—Oedema—Betamethasone—ankylosing spondylitis	0.000347	0.00192	CcSEcCtD
Alprostadil—Oedema—Dexamethasone—ankylosing spondylitis	0.000347	0.00192	CcSEcCtD
Alprostadil—Infection—Dexamethasone—ankylosing spondylitis	0.000344	0.00191	CcSEcCtD
Alprostadil—Infection—Betamethasone—ankylosing spondylitis	0.000344	0.00191	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000343	0.00203	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000343	0.00203	CbGpPWpGaD
Alprostadil—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000342	0.0019	CcSEcCtD
Alprostadil—Visual impairment—Methotrexate—ankylosing spondylitis	0.000342	0.0019	CcSEcCtD
Alprostadil—Anaemia—Prednisone—ankylosing spondylitis	0.000342	0.00189	CcSEcCtD
Alprostadil—Shock—Betamethasone—ankylosing spondylitis	0.000341	0.00189	CcSEcCtD
Alprostadil—Shock—Dexamethasone—ankylosing spondylitis	0.000341	0.00189	CcSEcCtD
Alprostadil—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000339	0.00188	CcSEcCtD
Alprostadil—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000339	0.00188	CcSEcCtD
Alprostadil—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000338	0.00187	CcSEcCtD
Alprostadil—Tachycardia—Betamethasone—ankylosing spondylitis	0.000338	0.00187	CcSEcCtD
Alprostadil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000336	0.00186	CcSEcCtD
Alprostadil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000335	0.00186	CcSEcCtD
Alprostadil—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000335	0.00186	CcSEcCtD
Alprostadil—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000335	0.00186	CcSEcCtD
Alprostadil—Syncope—Prednisone—ankylosing spondylitis	0.000332	0.00184	CcSEcCtD
Alprostadil—Pain—Triamcinolone—ankylosing spondylitis	0.000327	0.00181	CcSEcCtD
Alprostadil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000325	0.0018	CcSEcCtD
Alprostadil—Hypotension—Dexamethasone—ankylosing spondylitis	0.000324	0.00179	CcSEcCtD
Alprostadil—Hypotension—Betamethasone—ankylosing spondylitis	0.000324	0.00179	CcSEcCtD
Alprostadil—Convulsion—Prednisone—ankylosing spondylitis	0.00032	0.00177	CcSEcCtD
Alprostadil—Hypertension—Prednisone—ankylosing spondylitis	0.000319	0.00177	CcSEcCtD
Alprostadil—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000315	0.00174	CcSEcCtD
Alprostadil—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000314	0.00174	CcSEcCtD
Alprostadil—Discomfort—Prednisone—ankylosing spondylitis	0.000311	0.00172	CcSEcCtD
Alprostadil—Erythema—Methotrexate—ankylosing spondylitis	0.000309	0.00171	CcSEcCtD
Alprostadil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000305	0.00169	CcSEcCtD
Alprostadil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000305	0.00169	CcSEcCtD
Alprostadil—ABCC5—Metabolism—B3GNT2—ankylosing spondylitis	0.000304	0.0018	CbGpPWpGaD
Alprostadil—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000302	0.00167	CcSEcCtD
Alprostadil—Oedema—Prednisone—ankylosing spondylitis	0.000302	0.00167	CcSEcCtD
Alprostadil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000301	0.00167	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.0003	0.00177	CbGpPWpGaD
Alprostadil—Infection—Prednisone—ankylosing spondylitis	0.0003	0.00166	CcSEcCtD
Alprostadil—Back pain—Methotrexate—ankylosing spondylitis	0.000299	0.00166	CcSEcCtD
Alprostadil—Shock—Prednisone—ankylosing spondylitis	0.000297	0.00164	CcSEcCtD
Alprostadil—Pain—Dexamethasone—ankylosing spondylitis	0.000296	0.00164	CcSEcCtD
Alprostadil—Pain—Betamethasone—ankylosing spondylitis	0.000296	0.00164	CcSEcCtD
Alprostadil—Tachycardia—Prednisone—ankylosing spondylitis	0.000295	0.00163	CcSEcCtD
Alprostadil—Skin disorder—Prednisone—ankylosing spondylitis	0.000293	0.00162	CcSEcCtD
Alprostadil—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000292	0.00162	CcSEcCtD
Alprostadil—Anaemia—Methotrexate—ankylosing spondylitis	0.000286	0.00158	CcSEcCtD
Alprostadil—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000286	0.00158	CcSEcCtD
Alprostadil—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000286	0.00158	CcSEcCtD
Alprostadil—Dizziness—Prednisolone—ankylosing spondylitis	0.000275	0.00152	CcSEcCtD
Alprostadil—Asthenia—Triamcinolone—ankylosing spondylitis	0.000274	0.00152	CcSEcCtD
Alprostadil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000274	0.00152	CcSEcCtD
Alprostadil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000274	0.00152	CcSEcCtD
Alprostadil—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000274	0.00152	CcSEcCtD
Alprostadil—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000274	0.00152	CcSEcCtD
Alprostadil—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000273	0.00151	CcSEcCtD
Alprostadil—Pruritus—Triamcinolone—ankylosing spondylitis	0.00027	0.0015	CcSEcCtD
Alprostadil—Cough—Methotrexate—ankylosing spondylitis	0.00027	0.00149	CcSEcCtD
Alprostadil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00027	0.00149	CcSEcCtD
Alprostadil—Convulsion—Methotrexate—ankylosing spondylitis	0.000268	0.00148	CcSEcCtD
Alprostadil—Dyspepsia—Prednisone—ankylosing spondylitis	0.000266	0.00147	CcSEcCtD
Alprostadil—Rash—Prednisolone—ankylosing spondylitis	0.000262	0.00145	CcSEcCtD
Alprostadil—Dermatitis—Prednisolone—ankylosing spondylitis	0.000262	0.00145	CcSEcCtD
Alprostadil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000261	0.00144	CcSEcCtD
Alprostadil—Headache—Prednisolone—ankylosing spondylitis	0.00026	0.00144	CcSEcCtD
Alprostadil—Discomfort—Methotrexate—ankylosing spondylitis	0.00026	0.00144	CcSEcCtD
Alprostadil—Dizziness—Triamcinolone—ankylosing spondylitis	0.000253	0.0014	CcSEcCtD
Alprostadil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000252	0.0014	CcSEcCtD
Alprostadil—Infection—Methotrexate—ankylosing spondylitis	0.000251	0.00139	CcSEcCtD
Alprostadil—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000249	0.00138	CcSEcCtD
Alprostadil—Asthenia—Betamethasone—ankylosing spondylitis	0.000249	0.00138	CcSEcCtD
Alprostadil—Asthenia—Dexamethasone—ankylosing spondylitis	0.000249	0.00138	CcSEcCtD
Alprostadil—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000247	0.00137	CcSEcCtD
Alprostadil—Nausea—Prednisolone—ankylosing spondylitis	0.000247	0.00137	CcSEcCtD
Alprostadil—Pruritus—Dexamethasone—ankylosing spondylitis	0.000245	0.00136	CcSEcCtD
Alprostadil—Pruritus—Betamethasone—ankylosing spondylitis	0.000245	0.00136	CcSEcCtD
Alprostadil—Skin disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00136	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000244	0.00144	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000244	0.00144	CbGpPWpGaD
Alprostadil—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000244	0.00135	CcSEcCtD
Alprostadil—Rash—Triamcinolone—ankylosing spondylitis	0.000241	0.00133	CcSEcCtD
Alprostadil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000241	0.00133	CcSEcCtD
Alprostadil—Rash—Methylprednisolone—ankylosing spondylitis	0.00024	0.00133	CcSEcCtD
Alprostadil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00024	0.00133	CcSEcCtD
Alprostadil—Headache—Triamcinolone—ankylosing spondylitis	0.000239	0.00133	CcSEcCtD
Alprostadil—Headache—Methylprednisolone—ankylosing spondylitis	0.000239	0.00132	CcSEcCtD
Alprostadil—Abdominal pain—Prednisone—ankylosing spondylitis	0.000239	0.00132	CcSEcCtD
Alprostadil—Body temperature increased—Prednisone—ankylosing spondylitis	0.000239	0.00132	CcSEcCtD
Alprostadil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000237	0.00131	CcSEcCtD
Alprostadil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000237	0.00131	CcSEcCtD
Alprostadil—Hypotension—Methotrexate—ankylosing spondylitis	0.000236	0.00131	CcSEcCtD
Alprostadil—Dizziness—Dexamethasone—ankylosing spondylitis	0.000229	0.00127	CcSEcCtD
Alprostadil—Dizziness—Betamethasone—ankylosing spondylitis	0.000229	0.00127	CcSEcCtD
Alprostadil—Nausea—Triamcinolone—ankylosing spondylitis	0.000227	0.00126	CcSEcCtD
Alprostadil—Nausea—Methylprednisolone—ankylosing spondylitis	0.000226	0.00125	CcSEcCtD
Alprostadil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000222	0.00123	CcSEcCtD
Alprostadil—Rash—Dexamethasone—ankylosing spondylitis	0.000219	0.00121	CcSEcCtD
Alprostadil—Rash—Betamethasone—ankylosing spondylitis	0.000219	0.00121	CcSEcCtD
Alprostadil—Dermatitis—Betamethasone—ankylosing spondylitis	0.000218	0.00121	CcSEcCtD
Alprostadil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000218	0.00121	CcSEcCtD
Alprostadil—Headache—Dexamethasone—ankylosing spondylitis	0.000217	0.0012	CcSEcCtD
Alprostadil—Headache—Betamethasone—ankylosing spondylitis	0.000217	0.0012	CcSEcCtD
Alprostadil—Asthenia—Prednisone—ankylosing spondylitis	0.000217	0.0012	CcSEcCtD
Alprostadil—Pain—Methotrexate—ankylosing spondylitis	0.000216	0.00119	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000214	0.00126	CbGpPWpGaD
Alprostadil—Pruritus—Prednisone—ankylosing spondylitis	0.000214	0.00118	CcSEcCtD
Alprostadil—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000208	0.00115	CcSEcCtD
Alprostadil—Diarrhoea—Prednisone—ankylosing spondylitis	0.000207	0.00114	CcSEcCtD
Alprostadil—Nausea—Dexamethasone—ankylosing spondylitis	0.000206	0.00114	CcSEcCtD
Alprostadil—Nausea—Betamethasone—ankylosing spondylitis	0.000206	0.00114	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000203	0.0012	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000203	0.0012	CbGpPWpGaD
Alprostadil—Dizziness—Prednisone—ankylosing spondylitis	0.0002	0.00111	CcSEcCtD
Alprostadil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000199	0.0011	CcSEcCtD
Alprostadil—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000199	0.0011	CcSEcCtD
Alprostadil—Rash—Prednisone—ankylosing spondylitis	0.00019	0.00105	CcSEcCtD
Alprostadil—Dermatitis—Prednisone—ankylosing spondylitis	0.00019	0.00105	CcSEcCtD
Alprostadil—Headache—Prednisone—ankylosing spondylitis	0.000189	0.00105	CcSEcCtD
Alprostadil—Asthenia—Methotrexate—ankylosing spondylitis	0.000181	0.001	CcSEcCtD
Alprostadil—Nausea—Prednisone—ankylosing spondylitis	0.000179	0.000993	CcSEcCtD
Alprostadil—Pruritus—Methotrexate—ankylosing spondylitis	0.000178	0.000989	CcSEcCtD
Alprostadil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000173	0.000956	CcSEcCtD
Alprostadil—Dizziness—Methotrexate—ankylosing spondylitis	0.000167	0.000924	CcSEcCtD
Alprostadil—Rash—Methotrexate—ankylosing spondylitis	0.000159	0.000881	CcSEcCtD
Alprostadil—Dermatitis—Methotrexate—ankylosing spondylitis	0.000159	0.00088	CcSEcCtD
Alprostadil—Headache—Methotrexate—ankylosing spondylitis	0.000158	0.000875	CcSEcCtD
Alprostadil—Nausea—Methotrexate—ankylosing spondylitis	0.00015	0.00083	CcSEcCtD
Alprostadil—ABCC5—Disease—HLA-A—ankylosing spondylitis	0.000147	0.000868	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000144	0.000854	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP3—ankylosing spondylitis	0.000144	0.000854	CbGpPWpGaD
